HHealthcare Read More UnitedHealth Group (UNH) earnings Q3 2026October 13, 2026 UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle…
HHealthcare Read More Humana surges after topping 2027 Medicare star ratingsOctober 9, 2026 Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Saturday, Feb. 2, 2019.…
BBusiness Read More AstraZeneca CEO says Summit drug could drive future cancer combosOctober 5, 2026 AstraZeneca CEO Pascal Soriot told CNBC on Monday that Summit Therapeutics‘ lead drug could help power next-generation cancer…
MMedication Read More Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trialOctober 1, 2026 Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose…
MMedication Read More Novo’s Wegovy pill improves weight loss after switch from injectionsSeptember 30, 2026 People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…
MMedication Read More Ozempic counterfeit ring charges against Indian nationals unsealedSeptember 29, 2026 Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…
HHealthcare Read More Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli LillySeptember 25, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
HHealthcare Read More Novo Nordisk CEO on rebuilding investor trust after backlashSeptember 24, 2026 Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…
HHealthcare Read More Eli Lilly CEO David Ricks discusses GLP-1s and Medicare coverageSeptember 21, 2026 Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…
HHealthcare Read More Lilly is ramping up future manufacturing for Foundayo obesity pillSeptember 21, 2026 Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…
BBusiness Read More Advil-maker Haleon targets consumers on weight-loss drugsSeptember 16, 2026 Michael Siluk | UCG | Universal Images Group | Getty Images Consumer health company Haleon has achieved growing sales of…
HHealthcare Read More Novo Nordisk rebrands to ‘Novo’ under CEO Mike DoustdarSeptember 14, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…